Aditxt Inc. - ADTX Market Valuation

Official company branding of Aditxt, Inc. (ADTX)

Aditxt (ADTX) develops advanced control systems for the body's defense mechanisms, helping to achieve immune response harmony to extend life. The business is currently transforming, relying on the acquisition of niche biotech projects and the pursuit of new investments. This chart of quotes with a market capitalization of 0.01 reflects the dynamics of an asset whose success is tied to the implementation of AditxtScore and the expansion of its diagnostic center network.

ADTX (Aditxt Inc.) Market Capitalization history from 07/04/2022 to 07/11/2026

Comprehensive metric breakdowns and analytics for aditxt.com (ADTX)

- current price and projected stock value:
Stock Price Aditxt, Inc.|ADTX - Broker Consensus Forecast
- issuer market value details:
Market Valuation Aditxt, Inc.|ADTX - Aggregate Business Value
- business book valuation details:
Accounting Value per Share Aditxt|ADTX - Accounting Capitalization|Market Value to Book Value Ratio aditxt.com|ADTX - Total Asset Value of Company
- debt obligations and liquidity statistics:
Total Debt to Capital Aditxt|ADTX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Aditxt, Inc.|ADTX - Company Aggregate Debts|Debt to Book Capitalization Ratio Aditxt, Inc.|ADTX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Aditxt|Quick Ratio aditxt.com
- net income and valuation multiples indicators:
ADTX - Net Profit|Future Profit Aditxt|ADTX - Company Value to Net Income|Forward P/E Multiple Aditxt, Inc.|ADTX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aditxt, Inc.|ADTX - Operating profit before deduction of amortization|Earnings per share for the last twelve months Aditxt|ADTX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months aditxt.com|ADTX - Earnings growth in current year|Net earnings per share growth forecast for next year Aditxt
Fundamental company analysis:ADTX (Aditxt Corp)
Product sample of aditxt.com

Market capitalization reflects the aggregate value of all company shares, determining its actual weight within the market structure. By analyzing the capitalization volumes of a company, an investor assesses the market discount of fundamental risks and fiscal shocks. The metric is calculated by multiplying the current share price by the total number of issued securities. For Aditxt (ADTX), this metric captures the stability of the underlying flows of commercial laboratories. Moving forward, it will serve as an indicator of the integration efficiency of new M&A assets.

Key competitors

Market Capitalization ARGX (argenx)|BNTX: Market Capitalization|ABVX: Market Valuation|ADMA Corp - Market Value|PTGX (Protagonist Therapeutics) - Market Valuation|Market Capitalization IMVT|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|JBIO - Market Capitalization|ACRS: Market Capitalization|Market Capitalization KYTX|TLSA (Tiziana Life Sciences Ltd) - Market Capitalization|Cabaletta Bio Inc. (CABA) - Market Capitalization|Market Valuation VTYX (Ventyx Bio)|Market Value THTX|Avalo Therapeutics, Inc - Market Valuation|ELDN: Market Capitalization|AGEN: Market Valuation|Climb Bio Inc. - Market Value|ZURA: Market Capitalization|aTyr Pharmaceuticals (ATYR) - Market Capitalization|ADAG (Adagene Inc) - Market Capitalization|Market Capitalization IMA (Ikena Oncology, Inc.)|Market Valuation STTK (Shattuck Labs, Inc.)|Market Value EQ|Connect Biopharma Holdings Limited - Market Valuation|IMUX: Market Capitalization|ATRA - Market Value|Market Valuation IFRX|XFOR: Market Capitalization|Adicet Bio, Inc. - Market Value|CELU (Celularity Inc) - Market Capitalization|Market Capitalization INmune Bio Corporation|Market Value Barinthus Biotherapeutics (BRNS)|KZR (kezarlifesciences.com) - Market Value|Market Value SAB Biotherapeutics, Inc. SABS|AKTX - Market Valuation|Enlivex Therapeutics, Ltd. - Market Capitalization|QTTB - Market Capitalization|GOVX (GeoVax Labs, Inc.) - Market Valuation|edesabiotech.com - Market Value|IBIO (iBio) - Market Capitalization|Carisma Tx (CARM) - Market Capitalization|Market Value XTL Biopharmaceuticals, Ltd. (XTLB)|Market Valuation boltbio.com BOLT|Market Value HCW Biologics HCWB|APVO - Market Valuation|AIM: Market Valuation|GRI - Market Capitalization|XORTX (XRTX) - Market Value|Market Capitalization HIND|REVB (Revelation Biosciences) - Market Capitalization|Market Value indaptusrx.com INDP|Market Capitalization SCNI|Market Capitalization calcimedica.com (CALI)|Market Capitalization AFMD (Affimed N.V.)|ALLK: Market Capitalization|HOOKIPA - Market Capitalization|Market Capitalization IGM Biosciences, Inc. IGMS|ITOS (iTeos Therapeutics, Inc.) - Market Valuation|OCEA: Market Value|Market Valuation TCBP|Market Capitalization THRD (Third Harmonic Bio Inc)